Kyu-Sik Kim
Overview
Explore the profile of Kyu-Sik Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Oh I, Kim H, Song S, Na K, Kim K, Kim Y, et al.
Thorac Cancer
. 2016 Jan;
5(5):425-30.
PMID: 26767034
Background: We selected glutathione peroxidase 3 (GPx3) as a specific candidate that is down regulated in patients with lung cancer. In this study, we examined the diagnostic value of serum...
12.
Lee B, Oh I, Lee H, Ban H, Kim K, Kim Y, et al.
Clin Exp Otorhinolaryngol
. 2015 Dec;
8(4):396-401.
PMID: 26622961
Objectives: Argon plasma coagulation (APC) is a noncontact form of electrocautery that utilizes ionized argon as the electrical current. A rigid bronchoscopic use of APC for the management of central...
13.
Kim Y, Ahn S, Kim Y, Kim K, Oh I, Ban H, et al.
Jpn J Clin Oncol
. 2015 Nov;
46(2):144-51.
PMID: 26590014
Objective: Concurrent chemoradiotherapy is the standard treatment for locally advanced Stage III non-small cell lung cancer in patients with a good performance status and minimal weight loss. This study aimed...
14.
Kim W, Kim S, Choi H, Chang J, Shin H, Park C, et al.
Thorac Cancer
. 2015 Nov;
6(6):800-4.
PMID: 26557922
Several cases of acquired resistance in patients with activating epidermal growth factor receptor (EGFR) mutation have been reported. However, rare clinical cases exist of a transformation to small cell lung...
15.
Choi H, Chang J, Shin H, Park C, Oh I, Kim K, et al.
Thorac Cancer
. 2015 Aug;
6(2):224-6.
PMID: 26273363
We report a case showing the long-term clinical benefit of the continued use of gefitinib in a patient with asymptomatic progression of lung adenocarcinoma harboring an exon 19 deletion of...
16.
Kim Y, Choi Y, Kim S, Park Y, Oh I, Kim K, et al.
Complement Ther Med
. 2015 Jun;
23(3):381-7.
PMID: 26051573
Objective: To investigate the effect of combining conventional treatment with regional hyperthermia on cancer pain in lung cancer patients. Design: Case-control study. Setting: One Korean university hospital and three complementary...
17.
Lee B, Yu J, Yoon S, Ban H, Kwon Y, Oh I, et al.
J Thorac Dis
. 2015 Apr;
7(3):433-8.
PMID: 25922722
Background: Tegafur-uracil (UFT) is an anticancer agent that inhibits thymidylate synthase (TS). The degree of TS expression in primary lung cancer (LC) is different according to histologic cell type. In...
18.
Yoon S, Choi Y, Oh I, Kim K, Choi H, Chang J, et al.
Cancer Res Treat
. 2015 Feb;
47(4):661-9.
PMID: 25715768
Purpose: Direct sequencing (DS) is the standard method for detection of epidermal growth factor receptor (EGFR) gene mutation in non-small cell lung cancer (NSCLC); however, low detection sensitivity is a...
19.
Lim S, Leem D, Park K, Kim K, Sul S, Na K, et al.
Sci Rep
. 2015 Jan;
5:7708.
PMID: 25578322
Complementary metal-oxide-semiconductor (CMOS) colour image sensors are representative examples of light-detection devices. To achieve extremely high resolutions, the pixel sizes of the CMOS image sensors must be reduced to less...
20.
Kim S, Oh I, Park S, Song J, Seon H, Kim Y, et al.
J Thorac Dis
. 2014 Oct;
6(9):1209-17.
PMID: 25276362
Background: With the recent increased use of new anti-neoplastic agents, molecular-targeted drugs and radiation in patients with lung cancer, there has been an increase in the occurrence drug-induced or radiation-induced...